Expression of concern
The Clinical Relevance of Stromal Matrix Metalloproteinase Expression in Ovarian Cancer
Paper Information
Record ID:
31311
Author(s):
Journal:
Publication Date:
March 21, 2006
Retraction Date:
August 02, 2021
(4.3 years years ago)
Subjects:
Broad Categories:
Biology
Biology
Institutions:
- Department of Gynecologic Oncology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
- Department of Biostatistics and Applied Mathematics, University of Texas M.D. Anderson Cancer Center, Houston, Texas
- Department of Cancer Biology, University of Texas M.D. Anderson Cancer Center, Houston, Texas
- Department of Pathology, University of Iowa Hospitals and Clinics, Iowa City, Iowa
Country:
đşđ¸ United StatesArticle Type:
Publisher:
American Association for Cancer Research
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Expression of concern Details
Retraction Reason:
Nature of Retraction:
Expression of concern
Retraction Notice:
10.1158/1078-0432.CCR-21-2121Citations (171)
171
Total Citations16
Post-Retraction(9.4%)
153
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
4
Within 1 year
5
After 2+ years
1416
Days since retraction (latest)
Matrix Metalloproteinase 9 Is a Mediator of Epidermal Growth FactorâDependent E-Cadherin Loss in Ovarian Carcinoma Cells
Karen D. Cowden Dahl, Jaime Symowicz, Yan Ning et al. (8 authors)
Cancer Research
Open Access
Published: Jun 2008
182 citations
182 citations
4796 days before retraction
Subcellular Localization of Activated Leukocyte Cell Adhesion Molecule Is a Molecular Predictor of Survival in Ovarian Carcinoma Patients
Delia Mezzanzanica, Marina Fabbi, Marina Bagnoli et al. (14 authors)
Clinical Cancer Research
Published: Mar 2008
92 citations
92 citations
4888 days before retraction
New therapies for ovarian cancer: Cytotoxics and molecularly targeted agents
Phuong Dinh, Paul R. Harnett, Martine Piccart et al. (4 authors)
Critical Reviews in Oncology/Hematology
Published: Mar 2008
77 citations
77 citations
4888 days before retraction
Tumour endoproteases: the cutting edge of cancer drug delivery?
Jennifer M. Atkinson, Catherine S. Siller, Jason H. Gill
British Journal of Pharmacology
Open Access
Published: Jan 2008
54 citations
54 citations
4942 days before retraction
Early Events in the Pathogenesis of Epithelial Ovarian Cancer
Charles N. Landen, Michael J. Birrer, Anil K. Sood
Journal of Clinical Oncology
Published: Jan 2008
435 citations
435 citations
4948 days before retraction
Label-Free Colorimetric Detection of Gelatinases on Nanoporous Silicon Photonic Films
Lizeng Gao, Njideka Mbonu, Liangliang Cao et al. (4 authors)
Analytical Chemistry
Published: Jan 2008
60 citations
60 citations
4951 days before retraction
Clinical and Biological Significance of Vascular Endothelial Growth Factor in Endometrial Cancer
Aparna A. Kamat, William M. Merritt, Donna Coffey et al. (14 authors)
Clinical Cancer Research
Open Access
Published: Dec 2007
182 citations
182 citations
4979 days before retraction
Significantly Greater Expression of ER, PR, and ECAD in Advanced-Stage Low-Grade Ovarian Serous Carcinoma as Revealed by Immunohistochemical Analysis
KwongâKwok Wong, Karen H. Lu, AnaĂs Malpica et al. (10 authors)
International Journal of Gynecological Pathology
Published: Oct 2007
138 citations
138 citations
5054 days before retraction
A biochemical mechanism for resistance of intervertebral discs to metastatic cancer: Fas ligand produced by disc cells induces apoptotic cell death of cancer cells
JongâBeom Park, JinâKyung Lee, Sung Tae Cho et al. (5 authors)
European Spine Journal
Open Access
Published: Aug 2007
14 citations
14 citations
5109 days before retraction
Ovarian Cancer Biomarkers: A Focus on Genomic and Proteomic Findings
Andrea Tinelli, Daniele Vergara, Roberta Martignago et al. (9 authors)
Current Genomics
Open Access
Published: Aug 2007
9 citations
9 citations
5115 days before retraction
PEA3 Is Necessary for Optimal Epidermal Growth Factor ReceptorâStimulated Matrix Metalloproteinase Expression and Invasion of Ovarian Tumor Cells
Karen D. Cowden Dahl, Reema Zeineldin, Laurie G. Hudson
Molecular Cancer Research
Open Access
Published: May 2007
53 citations
53 citations
5205 days before retraction
Engagement of Collagen-Binding Integrins Promotes Matrix Metalloproteinase-9âDependent E-Cadherin Ectodomain Shedding in Ovarian Carcinoma Cells
Jaime Symowicz, Brian P. Adley, Kara J. Gleason et al. (8 authors)
Cancer Research
Open Access
Published: Mar 2007
230 citations
230 citations
5268 days before retraction
Anatomic Site-Related Expression of Cancer-Associated Molecules in Ovarian Carcinoma
Ben Davidson
Current Cancer Drug Targets
Published: Feb 2007
18 citations
18 citations
5296 days before retraction
Prognostic Significance of Extracellular Matrix Metalloproteinase Inducer and Matrix Metalloproteinase 2 in Epithelial Ovarian Cancer
S. Sillanp auml auml, Maarit Anttila, Kirsi A. Suhonen et al. (10 authors)
Tumor Biology
Published: Jan 2007
41 citations
41 citations
5327 days before retraction
Increased Expression of the Pro-Protein Convertase Furin Predicts Decreased Survival in Ovarian Cancer
Robert E. Page, Andres J. KleinâSzanto, Samuel Litwin et al. (10 authors)
Analytical Cellular Pathology
Open Access
Published: Jan 2007
81 citations
81 citations
5327 days before retraction
Regulation Of Membrane-Type 1 Matrix Metalloproteinase In Prostate Cancer
Isis C. Sroka
Unknown Journal
Published: Jan 2007
5327 days before retraction
EphA2 overexpression is associated with angiogenesis in ovarian cancer
Yvonne G. Lin, Liz Y. Han, Aparna A. Kamat et al. (10 authors)
Cancer
Published: Dec 2006
112 citations
112 citations
5352 days before retraction
Mechanisms of transcoelomic metastasis in ovarian cancer
David S.P. Tan, Roshan Agarwal, Stanley B. Kaye
The Lancet Oncology
Published: Nov 2006
493 citations
493 citations
5388 days before retraction
Prognostic significance of matrix metalloproteinase-9 (MMP-9) in epithelial ovarian cancer
Sari Sillanpää, Maarit Anttila, Kirsi Voutilainen et al. (11 authors)
Gynecologic Oncology
Published: Oct 2006
75 citations
75 citations
5409 days before retraction
Relevant molecular markers and targets
Kathleen M. Darcy, Russell J. Schilder
Gynecologic Oncology
Open Access
Published: Oct 2006
16 citations
16 citations
5409 days before retraction
Expression of stromal MMPs affects clinical outcome in ovarian carcinoma
Rebecca Ireland
Nature Clinical Practice Oncology
Open Access
Published: Jun 2006
5541 days before retraction
Quick Stats
Total Citations:
171
Years Since Retraction:
4.3 years
Open Access:
Yes
Last Checked:
Jul 24, 2025